SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A quarterly earnings miss and sharply reduced full-year outlook, driven largely by heavier investment in DraftKings Predictions business, triggered a steep selloff. Traders mostly criticized management and questioned profitability amid competition from Kalshi and Polymarket, while some argued the core sportsbook remains healthy and the spending could build market share.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

FLY is drawing attention for a steep selloff alongside other space stocks, with traders pointing to macro and interest-rate concerns as well as worries about launch execution, possible delays, and cash burn. Some investors see the decline as a buying opportunity based on Fireflys long-term space and defense prospects, while others remain concerned about profitability and further downside.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles Firefly agreement to develop its own heavy-lift rocket has sparked debate over whether vertical integration can ease launch bottlenecks and reduce reliance on competing providers. Bulls view it as a long-term strategic step, while skeptics point to the cost, execution risk and potential dilution, especially amid delayed satellite launches.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulfs quarterly results and upbeat management call, alongside Googles credit support for financing tied to the Anthropic data-center lease, are driving attention; bulls see stronger project financing and AI/HPC prospects. The reaction remains divided, as traders weigh those developments against the sharp selloff, sector-wide data-center concerns, and uncertainty about regulation, debt, and buildout execution.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

A sharp selloff around Oklos quarterly update has focused discussion on its pre-revenue status, cash burn, and long path to commercial reactors. Some traders see the companys cash position and project progress as reasons for optimism, while others cite valuation concerns and reported insider selling as risks of further dilution.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers agreement with Eli Lilly to offer eligible patients access to Zepbound and Foundayo through its platform is driving attention, with traders viewing the branded weight-loss drugs as an expansion of Hims offerings. Reactions are mixed: some see a meaningful growth opportunity, while skeptics question the deals economics and whether the announcement will translate into sustained stock gains.

Airbnb, Inc. engages in the management and operation of an online marketplace. Its marketplace model connects hosts and guests online or through mobile devices to book spaces. The company was founded by Brian Chesky, Nathan Blecharczyk and Joseph Gebbia in 2007 and is headquartered in San Francisco, CA.

Airbnb Inc - Ordinary Shares - Class A

Airbnb Inc

Airbnbs quarterly earnings beat and raised outlook, alongside a new buyback authorization and analyst target hikes, are driving attention. Bulls point to accelerating bookings and resilient travel demand, while skeptics question whether market weakness, margin concerns, and profit-taking could outweigh the strong report.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamais latest earnings and outlook are driving attention, as traders weigh an expected acceleration in 2027 growth and expanding cloud/AI commitments against heavy capital spending and questions about returns. Some see the call and backlog as bullish, while others remain concerned about the spending burden and weak share-price reaction.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigels quarterly results have sparked a sharp selloff, with bearish traders focused on the earnings and profitability concerns while bullish holders point to record product sales and a promising early VEPPANU launch. The debate centers on whether the new drugs growth can offset pressure in the established business and justify the launch-related costs.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Deramiocels FDA decision for Duchenne muscular dystrophy, with a November 22 target date, is the dominant focus; traders are weighing HOPE-3 upper-limb results and a letter from 28 trial investigators urging approval against concerns about the FDAs assessment of the data. Many are bullish and speculate about short-covering if the drug is approved, while others stress that approval is uncertain and a rejection or delay remains possible.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
